Title	Hormone Therapy in Breast and Prostate Cancer [electronic resource] / edited by V. Craig Jordan, Barrington J.A. Furr
Imprint	Totowa, NJ : Humana Press, 2002
Edition	1
Connect to	http://dx.doi.org/10.1007/978-1-59259-152-7
Descript	XIV, 420 p. 36 illus. online resource

Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide. Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics

An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer -- An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer -- Preclinical Antiestrogens -- Antiestrogens and the Cell Cycle -- Drug Resistance to Antiestrogens -- Mechanisms of Liver Carcinogenesis by Antiestrogens -- The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat -- Preclinical Studies of Raloxifene and Related Compounds -- Pure Antiestrogens -- Antiestrogens: Clinical -- Tamoxifen for the Treatment of Breast Cancer -- Clinical Utility of New Antiestrogens -- Breast-Cancer Prevention with Antiestrogens -- Inhibition of Estrogen Synthesis -- Aromatase Inhibitors -- Clinical Utility of Aromatase Inhibitors -- LH-RH Agonists for the Treatment of Breast Cancer -- Androgens and Androgen Withdrawal -- Molecular Action of Androgens -- Steroidal Antiandrogens -- Nonsteroidal Antiandrogens -- LH-RH Agonist Role in Prostate Cancer Management -- Perspective on Progress -- Recent Progress in Breast Cancer Research

1. Medicine
2. Cancer research
3. Pharmacology
4. Oncology
5. Medicine & Public Health
6. Oncology
7. Cancer Research
8. Pharmacology/Toxicology